- Home
- CARM vs BGI Comparison
CARM vs BGI Comparison
Compare CARM & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- BGI
- Stock Information
- Founded
- CARM 2016
- BGI 1879
- Country
- CARM United States
- BGI Canada
- Employees
- CARM N/A
- BGI N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- CARM Health Care
- BGI
- Exchange
- CARM Nasdaq
- BGI Nasdaq
- Market Cap
- CARM 19.7M
- BGI 23.4M
- IPO Year
- CARM N/A
- BGI 2005
- Fundamental
- Price
- CARM $0.45
- BGI $1.18
- Analyst Decision
- CARM Hold
- BGI
- Analyst Count
- CARM 5
- BGI 0
- Target Price
- CARM $4.57
- BGI N/A
- AVG Volume (30 Days)
- CARM 512.7K
- BGI 449.2K
- Earning Date
- CARM 03-31-2025
- BGI 11-27-2024
- Dividend Yield
- CARM N/A
- BGI N/A
- EPS Growth
- CARM N/A
- BGI N/A
- EPS
- CARM N/A
- BGI N/A
- Revenue
- CARM $20,268,000.00
- BGI $131,596,264.00
- Revenue This Year
- CARM $46.34
- BGI N/A
- Revenue Next Year
- CARM N/A
- BGI N/A
- P/E Ratio
- CARM N/A
- BGI N/A
- Revenue Growth
- CARM 41.13
- BGI 4.01
- 52 Week Low
- CARM $0.38
- BGI $1.03
- 52 Week High
- CARM $2.77
- BGI $3.98
- Technical
- Relative Strength Index (RSI)
- CARM 44.17
- BGI 36.03
- Support Level
- CARM $0.43
- BGI $1.11
- Resistance Level
- CARM $0.50
- BGI $1.31
- Average True Range (ATR)
- CARM 0.05
- BGI 0.15
- MACD
- CARM 0.00
- BGI -0.02
- Stochastic Oscillator
- CARM 28.16
- BGI 18.83
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.